<?xml version="1.0" encoding="UTF-8"?>
<p id="Par36">Omacetaxine mepesuccinate (trade names Synribo), formerly named as homoharringtonine (
 <bold>16</bold>), is a plant alkaloid derived from 
 <italic>Cephalotaxus fortunei</italic> Hook that was approved by the US FDA in October 2012 for the treatment of chronic myeloid leukemia in adults. Homoharringtonine has been reported to exhibit potent inhibitory activity against coronaviruses, namely porcine epidemic diarrhea virus, murine hepatitis virus (Dong et al. 
 <xref ref-type="bibr" rid="CR27">2018</xref>; Andersen et al. 
 <xref ref-type="bibr" rid="CR2">2019</xref>), and SARS-CoV-2 with EC
 <sub>50</sub> at 2.10 μM (Choy et al. 
 <xref ref-type="bibr" rid="CR22">2020</xref>).
</p>
